Dr Maximus Berger
Honorary (Fellow)
Centre for Youth Mental Health (Orygen)
65 Scholarly works
1 Projects
HIGHLIGHTS
2024
Journal article
The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial
DOI: 10.1016/j.biopsych.2023.06.0152023
Journal article
Acceptability and feasibility of a multidomain harmonized data collection protocol in youth mental health
DOI: 10.1111/eip.133462022
Journal article
Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis
DOI: 10.1038/s41398-022-02217-02022
Journal article
Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial
DOI: 10.1192/bjo.2022.5722022
Journal article
Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial
DOI: 10.4088/JCP.21m141302022
Journal article
Medicinal cannabis for the treatment of anxiety disorders
DOI: 10.31128/AJGP-04-21-59362019
Research Grant
Development and Validation of a Biomarker-Guided Risk Index for the Prediction of Clinical Outcomes in Young People at Ultra-High Risk for Psychosis.
RECENT SCHOLARLY WORKS
2022
Journal article
Machine learning based prediction and the influence of complement – Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial
DOI: 10.1016/j.bbi.2022.03.0132022
Journal article
Cannabidiol for at risk for psychosis youth: A randomized controlled trial
DOI: 10.1111/eip.131822022
Journal article
The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial
DOI: 10.1016/j.bbi.2021.09.0182021
Journal article
Editorial: Clinical High Risk for Psychosis: From Epidemiological Findings to Neurobiological Underpinnings of Treatment Response and Outcome
DOI: 10.3389/fpsyt.2021.790810